CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma

BACKGROUND: Infiltrating bladder urothelial carcinoma is the most common bladder malignancy with limited therapeutic options and poor prognosis. Identifying new therapeutic targets or strategies has important clinical significance. The data from public sources indicate poor prognosis in urothelial c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ran, Wang, Xuemei, Zhang, Leichao, Gu, Yu, Yang, Shaojuan, Wang, Liping, Wang, Xueju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024172/
https://www.ncbi.nlm.nih.gov/pubmed/35463324
http://dx.doi.org/10.3389/fonc.2022.819003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024172/
https://www.ncbi.nlm.nih.gov/pubmed/35463324
http://dx.doi.org/10.3389/fonc.2022.819003

Ejemplares similares